Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse Chromogranin B ELISA Kit (AC2757)
Cat.#: ASET-1346
Specifications
Description Mouse Chromogranin B ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Chromogranin B concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 2.34 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 40-640 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1642 Human Laminin ELISA Kit (AC3053) Quantitative inquiry ASET-1213 Sheep BDNF ELISA Kit (AC2624) Quantitative inquiry ASET-1488 Human VAP1 ELISA Kit (AC2899) Quantitative inquiry ASET-2497 Mouse Midkine ELISA Kit (AC3908) Quantitative inquiry ASET-2308 Human Gli1 ELISA Kit (AC3719) Quantitative inquiry ASET-1088 Mouse NMDAR2B ELISA Kit (AC2499) Quantitative inquiry ASET-2019 Rat CD45 ELISA Kit (AC3430) Quantitative inquiry ASET-1151 Human PER1 ELISA Kit (AC2562) Quantitative inquiry ASET-2534 Human Orexin Receptor 2 ELISA Kit (AC3945) Quantitative inquiry ASET-1759 Human FGFR1 ELISA Kit (AC3170) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket